Unjha Formulations Yönetim

Yönetim kriter kontrolleri 4/4

Unjha Formulations CEO'su Kruti Patel, May2023 tarihinde atandı, in görev süresi 1.5 yıldır. in toplam yıllık tazminatı ₹ 1.24M olup, şirket hissesi ve opsiyonları dahil olmak üzere 100% maaş ve 0% ikramiyelerden oluşmaktadır. şirketin hisselerinin 14.89% ine doğrudan sahiptir ve bu hisseler ₹ 18.28M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.8 yıl ve 9.8 yıldır.

Anahtar bilgiler

Kruti Patel

İcra Kurulu Başkanı

₹1.2m

Toplam tazminat

CEO maaş yüzdesi	100.0%
CEO görev süresi	1.5yrs
CEO sahipliği	14.9%
Yönetim ortalama görev süresi	4.8yrs
Yönetim Kurulu ortalama görev süresi	9.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Kruti Patel'un ücretlendirmesi Unjha Formulations'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	₹8m
Jun 30 2024	n/a	n/a	₹8m
Mar 31 2024	₹1m	₹1m	₹3m
Dec 31 2023	n/a	n/a	₹2m
Sep 30 2023	n/a	n/a	-₹2m
Jun 30 2023	n/a	n/a	₹4m
Mar 31 2023	₹520k	₹520k	₹3m
Dec 31 2022	n/a	n/a	₹4m
Sep 30 2022	n/a	n/a	₹6m
Jun 30 2022	n/a	n/a	-₹2m
Mar 31 2022	₹275k	₹275k	₹3m
Dec 31 2021	n/a	n/a	₹591k
Sep 30 2021	n/a	n/a	-₹312k
Jun 30 2021	n/a	n/a	₹3m
Mar 31 2021	₹455k	₹455k	₹1m
Dec 31 2020	n/a	n/a	₹696k
Sep 30 2020	n/a	n/a	₹2m
Jun 30 2020	n/a	n/a	₹2m
Mar 31 2020	₹455k	₹455k	₹3m
Dec 31 2019	n/a	n/a	₹5m
Sep 30 2019	n/a	n/a	₹5m
Jun 30 2019	n/a	n/a	₹5m
Mar 31 2019	₹455k	₹455k	₹3m
Dec 31 2018	n/a	n/a	₹2m
Sep 30 2018	n/a	n/a	₹3m
Jun 30 2018	n/a	n/a	₹4m
Mar 31 2018	₹455k	₹455k	₹3m

Tazminat ve Piyasa: Kruti 'nin toplam tazminatı ($USD 14.64K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 42.67K ).

Tazminat ve Kazançlar: Kruti 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Kruti Patel (61 yo)

1.5yrs

Görev süresi

₹1,236,804

Tazminat

Mrs. Krutiben Mayankkumar Patel, also known as Kruti, had been a Whole-Time Director of Unjha Formulations Limited since September 1, 2012 until May 10, 2023 and has been its Managing Director since May 10...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Krutiben Patel	MD, Compliance Officer & Director	1.5yrs	₹1.24m	14.89% ₹ 18.7m
Ganpatbhai Prajapati	Chief Financial Officer	9.2yrs	Veri yok	Veri yok
Jigar Ray	Company Secretary	4.8yrs	Veri yok	Veri yok

4.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim: 531762 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Krutiben Patel	MD, Compliance Officer & Director	12.2yrs	₹1.24m	14.89% ₹ 18.7m
Hasmukh Darji	Independent Non-Executive Director	23.5yrs	Veri yok	Veri yok
Jashodaben Patel	Chairman	10.8yrs	Veri yok	16.51% ₹ 20.7m
Jitendrakumar Limbachiya	Independent Non-Executive Director	8.8yrs	Veri yok	Veri yok
Esha Patel	Director	1.5yrs	₹541.73k	1.6% ₹ 2.0m
Mustufa Najmuddin Jodhpurwala	Independent & Non-Executive Director	3.8yrs	Veri yok	Veri yok

9.8yrs

Ortalama Görev Süresi

61yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 531762 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.8 yıldır).

Unjha Formulations Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Unjha Formulations Limited Approves the Appointment of Esha M. Patel as Executive Director

Unjha Formulations Limited Approves the Appointment of Esha M. Patel as Executive Director

Unjha Formulations Limited, Annual General Meeting, Aug 16, 2024

Unjha Formulations Limited, Annual General Meeting, Aug 31, 2023

Unjha Formulations Limited, Annual General Meeting, Aug 27, 2022

Recent updates

Second quarter 2025 earnings released: ₹0.25 loss per share (vs ₹0.26 loss in 2Q 2024)

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Now 20% undervalued

Unjha Formulations Limited to Report Q2, 2025 Results on Nov 08, 2024

Investor sentiment improves as stock rises 15%

Investor sentiment deteriorates as stock falls 16%

Now 21% undervalued after recent price drop

Now 20% undervalued

Unjha Formulations Limited Approves the Appointment of Esha M. Patel as Executive Director

Unjha Formulations Limited Approves the Appointment of Esha M. Patel as Executive Director

Now 20% undervalued

Full year 2024 earnings released: EPS: ₹0.62 (vs ₹0.63 in FY 2023)

Unjha Formulations Limited to Report Q1, 2025 Results on Aug 01, 2024

Unjha Formulations Limited, Annual General Meeting, Aug 16, 2024

Investor sentiment deteriorates as stock falls 16%

Full year 2024 earnings released: EPS: ₹0.62 (vs ₹0.63 in FY 2023)

Investor sentiment improves as stock rises 40%

Unjha Formulations Limited to Report Q4, 2024 Results on May 17, 2024

Investor sentiment improves as stock rises 19%

New major risk - Share price stability

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 27%

New minor risk - Share price stability

Third quarter 2024 earnings released: EPS: ₹0.87 (vs ₹0.21 loss in 3Q 2023)

Unjha Formulations Limited to Report Q3, 2024 Results on Jan 29, 2024

Second quarter 2024 earnings released: ₹0.26 loss per share (vs ₹1.23 profit in 2Q 2023)

Unjha Formulations Limited to Report Q2, 2024 Results on Nov 09, 2023

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 17%

First quarter 2024 earnings released: EPS: ₹0.40 (vs ₹0.10 in 1Q 2023)

Unjha Formulations Limited, Annual General Meeting, Aug 31, 2023

Investor sentiment deteriorates as stock falls 19%

Unjha Formulations Limited to Report Q1, 2024 Results on Aug 04, 2023

New major risk - Earnings quality

Investor sentiment improves as stock rises 15%

Third quarter 2023 earnings released: ₹0.21 loss per share (vs ₹0.04 profit in 3Q 2022)

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 17%

Unjha Formulations Limited to Report Nine Months, 2023 Results on Feb 10, 2023

Investor sentiment improved over the past week

Unjha Formulations Limited to Report First Half, 2023 Results on Nov 10, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Unjha Formulations Limited, Annual General Meeting, Aug 27, 2022

Unjha Formulations Limited to Report Q1, 2023 Results on Aug 04, 2022

Full year 2022 earnings released: EPS: ₹0.56 (vs ₹0.23 in FY 2021)

Unjha Formulations Limited to Report Q4, 2022 Results on May 02, 2022

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: ₹0.45 loss per share (vs ₹0.37 profit in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released: EPS ₹1.11 (vs ₹0.59 in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹0.23 (vs ₹0.69 in FY 2020)

Third quarter 2021 earnings released: ₹0.16 loss per share (vs ₹0.03 profit in 3Q 2020)

New 90-day high: ₹9.81

Unjha Formulations Limited to Report Q3, 2021 Results on Feb 06, 2021

New 90-day high: ₹8.65

New 90-day low: ₹6.84

Second quarter 2021 earnings released: EPS ₹0.37

Unjha Formulations Limited to Report First Half, 2021 Results on Nov 05, 2020

New 90-day high: ₹8.70

New 90-day high - ₹7.89

First quarter earnings released

New 90-day low - ₹5.31

CEO Tazminat Analizi

CEO